Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 1573-1576, 2005; 10.1373/clinchem.2005.051979
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Orazio, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Orazio, P.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Point-of-Care Testing
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2005;51:1573-1576.)
© 2005 American Association for Clinical Chemistry, Inc.


Special Report

Approved IFCC Recommendation on Reporting Results for Blood Glucose (Abbreviated)

Paul D’Orazio1, Robert W. Burnett2, Niels Fogh-Andersen3,a, Ellis Jacobs4, Katsuhiko Kuwa5, Wolf R. Külpmann6, Lasse Larsson7, Andrzej Lewenstam8, Anton H.J. Maas9, Gerhard Mager10, Jerzy W. Naskalski11, Anthony O. Okorodudu12 the International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing

1 Instrumetation Laboratory, Lexington, MA.
2 Hartford Hospital, Hartford, CT.
3 Herlev Hospital, Herlev, Denmark.
4 Wadsworth Center, Albany, NY.
5 University of Tsukuba, Tsukuba, Japan.
6 Medizinizche Hochschule, Hannover, Germany.
7 Univeristy of Linköping, Linköping, Sweden.
8 Åbo Akademi University, Åbo-Turku, Finland.
9 Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands.
10 Fresenius, Bad Homburg, Germany.
11 Jagiellonian University, Krakow, Poland.
12 Department of Pathology, University of Texas Medical Branch, Galveston, TX.

aAddress correspondence to this author at: Department of Clinical Biochemistry, Herlev Hospital, DK-2730 Herlev, Denmark. E-mail nifa{at}herlevhosp.kbhamt.dk.

In current clinical practice, plasma and blood glucose are used interchangeably with a consequent risk of clinical misinterpretation. In human blood, glucose, like water, is distributed between erythrocytes and plasma. The molality of glucose (amount of glucose per unit of water mass) is the same throughout the sample, but the concentration is higher in plasma because the concentration of water and, therefore, glucose is higher in plasma than in erythrocytes. Different devices for the measurement of glucose may detect and report fundamentally different quantities. Different water concentrations in calibrators, plasma, and erythrocyte fluid can explain some of the differences. Results of glucose measurements depend on sample type and on whether methods require sample dilution or use biosensors in undiluted samples. If the results are mixed up or used indiscriminately, the differences may exceed the maximum allowable error of glucose determinations for diagnosing and monitoring diabetes mellitus, and complicate the treatment. The goal of the IFCC Scientific Division Working Group on Selective Electrodes and Point of Care Testing (IFCC-SD, WG-SEPOCT) is to reach a global consensus on reporting results. The document recommends reporting the concentration of glucose in plasma (with the unit mmol/L), irrespective of sample type or measurement technique. A constant factor of 1.11 is used to convert concentration in whole blood to the equivalent concentration in the pertinent plasma. The conversion will provide harmonized results, facilitating the classification and care of patients and leading to fewer therapeutic misjudgments.




The following articles in journals at HighWire Press have cited this article:


Home page
HeartHome page
C. Strom Moller, B. Zethelius, J. Sundstrom, and L. Lind
Persistent ischaemic ECG abnormalities on repeated ECG examination have important prognostic value for cardiovascular disease beyond established risk factors: a population-based study in middle-aged men with up to 32 years of follow-up
Heart, September 1, 2007; 93(9): 1104 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. Dungan, J. Chapman, S. S. Braithwaite, and J. Buse
Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management
Diabetes Care, February 1, 2007; 30(2): 403 - 409.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. W. Steffes and D. B. Sacks
Measurement of Circulating Glucose Concentrations: The Time Is Now for Consistency among Methods and Types of Samples
Clin. Chem., September 1, 2005; 51(9): 1569 - 1570.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.